Browsing Harvard Medical School by Author "Campbell, Matthew"

Now showing items 1-2 of 2

    • Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation 

      Lewis, Huw D.; Liddle, John; Coote, Jim E.; Atkinson, Stephen J.; Barker, Michael D.; Bax, Benjamin, D.; Bicker, Kevin L.; Bingham, Ryan P.; Campbell, Matthew; Chen, Yu Hua; Chung, Chun-wa; Craggs, Peter D.; Davis, Rob P.; Eberhard, Dirk; Joberty, Gerard; Lind, Kenneth E.; Locke, Kelly; Maller, Claire; Martinod, Kimberly; Patten, Chris; Polyakova, Oxana; Rise, Cecil E.; Rüdiger, Martin; Sheppard, Robert J.; Slade, Daniel J.; Thomas, Pamela; Thorpe, Jim; Yao, Gang; Drewes, Gerard; Wagner, Denisa D.; Thompson, Paul R.; Prinjha, Rab K.; Wilson, David M. (2015)
      PAD4 has been strongly implicated in the pathogenesis of autoimmune, cardiovascular and oncological diseases, through clinical genetics and gene disruption in mice. Novel, selective PAD4 inhibitors binding to a calcium-deficient ...

    • Wnt Signaling Mediates Pathological Vascular Growth in Proliferative Retinopathy Clinical Perspective 

      Chen, Jing; Stahl, Andreas; Krah, Nathan M.; Seaward, Molly R.; Dennison, Roberta; Sapieha, Przemyslaw; Hua, Jing; Hatton, Colman J.; Juan, Aimee M.; Aderman, Christopher; Willett, Keirnan L.; Guerin, Karen I.; Mammoto, Akiko; Campbell, Matthew; Smith, Lois Elaine Hodgson (Ovid Technologies (Wolters Kluwer Health), 2011)
      BACKGROUND: Ischemic proliferative retinopathy, characterized by pathological retinal neovascularization, is a major cause of blindness in working-age adults and children. Defining the molecular pathways distinguishing ...